Top Results For: Valeant Pharmaceutical

The Toronto stock market was lower Monday as oil prices fell back as the news that al-Qaida leader Osama bin Laden has been killed strengthened the American dollar.

<p> Toronto Stock Exchange closes short week with four consecutive gains TORONTO - The Toronto stock market ended the last trading day of the quarter Thursday with a fourth consecutive session of gains. The S&P/TSX composite index added 111.93 points to 13,300.87, with every sector in positive territory a</p>

NEW YORK, N.Y. - Valeant Pharmaceuticals International Inc. has agreed to buy dermatology products maker Medicis Pharmaceutical Corp. for about $2.6 billion in cash in a deal to strengthen its position in skin treatments and care.

MONTREAL - Valeant Pharmaceuticals International Inc. expects to strengthen its position as a global leader in dermatology products with the $2.6-billion acquisition of U.S.-based Medicis Pharmaceutical Corp.

MONTREAL - Valeant Pharmaceuticals International Inc. (TSX:VRX), citing acquisition and other costs, has seen a sharp drop in third-quarter profits despite a healthy increase in revenue.

VANCOUVER - QLT Inc. (TSX:QLT) is cutting 27 jobs, or 42 per cent of its remaining workforce at the one-time heavyweight in Canada's biotechnology sector.

MONTREAL - Paladin Labs Inc. says it will sweeten its takeover bid for Afexa Life Sciences Inc., if the Cold-FX maker's two shareholder rights plans are waived by the Alberta Securities Commission.

TORONTO - The Toronto stock market surged more than 200 points Monday in its first trading after a wild week that saw global markets plummet on downbeat predictions for the U.S. economy and a growing mess in debt-laden European countries.

TORONTO - Some of the most active companies traded Monday on the Toronto Stock Exchange and the TSX Venture Exchange:

The Toronto stock market (TSX) surged more than 400 points Tuesday as investors bought up stocks that had been beaten down during a series of plunges.

TORONTO - Some of the most active companies traded Tuesday on the Toronto Stock Exchange and the TSX Venture Exchange:

TORONTO - The TSX turned around earlier losses to eke out a gain Thursday as investors watched commodity prices fall and took in weak U.S. economic data amid growing skepticism that a meeting of eurozone leaders will produce a meaningful solution to the region's growing debt crisis.

MONTREAL - Valeant Pharmaceuticals International (TSX:VRX) swung to a $21.6-million net loss in the second quarter on restructuring and acquisition charges, and also on the settlement costs of a class-action lawsuit against the company.

TORONTO - Some of the most active companies traded Friday on the Toronto Stock Exchange and the TSX Venture Exchange:

MONTREAL - Valeant Pharmaceuticals International Inc. (TSX:VRX) agreed to pay $71 million to acquire assets from Atlantis Pharma, a generics pharmaceutical company based in Mexico.

TORONTO - The Toronto stock market closed lower Monday after a strong run-up in oil prices in recent months raised questions about the durability of the global economic recovery.

TORONTO - The Toronto stock market closed higher Tuesday as the U.S. Federal Reserve offered further indications that the economic recovery south of the border is continuing at a steady but slow pace.

Stepping into the uproar over eye-popping price spikes for old generic medicines, a maker of compounded drugs will begin selling $1 doses of Daraprim, whose price recently was jacked up to $750 per pill by Turing Pharmaceuticals.

Quebec-based pharmaceutical giant says 2015 is shaping up to be more profitable than it thought, even as it undergoes scrutiny for dramatic price hikes.

The makers of Cold-fX are in court today fighting allegations they ignored their own research and misled consumers about the short-term effectiveness of the popular cold and flu remedy.